Effects and mechanisms of innate immune molecules on inhibiting nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects and mechanisms of innate immune molecules on inhibiting nasopharyngeal carcinoma

Published:2019-03-20 Issue:6 Volume:132 Page:749-752
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Xiong Fang,Deng Su,Huang Hong-Bin,Li Xia-Yu,Zhang Wen-Ling,Liao Qian-Jin,Ma Jian,Li Xiao-Ling,Xiong Wei,Li Gui-Yuan,Zeng Zhao-Yang,Guo Can

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference20 articles.

1. Human T-cell immunity against the emerging and re-emerging viruses;Zhao;Sci China Life Sci,2017

2. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway;Zhou;Int J Cancer,2008

3. BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM;Wei;Br J Cancer,2018

4. Effect of SPLUNC1 protein on the Pseudomonas aeruginosa and Epstein-Barr virus;Zhou;Mol Cell Biochem,2008

5. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways;Yang;PLoS One,2013

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitinase 3 like-1 activates the Akt pathway, inducing NF-κB-dependent release of pro-inflammatory cytokines and promoting the proliferative ability in nasopharyngeal carcinoma cells;Cytokine;2024-07

2. Micropeptides: potential treatment strategies for cancer;Cancer Cell International;2024-04-15

3. NLG-919 combined with cisplatin to enhance inhibitory effect on cell migration and invasion via IDO1–Kyn–AhR pathway in human nasopharyngeal carcinoma cell;Canadian Journal of Physiology and Pharmacology;2023-11-01

4. BPIFB1 promotes metastasis of hormone receptor‐positive breast cancer via inducing macrophage M2‐like polarization;Cancer Science;2023-09-13

5. LncRNA PVT1: as a therapeutic target for breast cancer;Pathology - Research and Practice;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3